Antithetic effect of interferon-[alpha] on cell-free and cell-to-cell HIV-1 infection

In HIV-1-infected individuals, transmitted/founder (TF) virus contributes to establish new infection and expands during the acute phase of infection, while chronic control (CC) virus emerges during the chronic phase of infection. TF viruses are more resistant to interferon-alpha (IFN-[alpha])-mediat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PLoS computational biology 2022-04, Vol.18 (4)
Hauptverfasser: Kumata, Ryuichi, Iwanami, Shoya, Mar, Katrina B, Kakizoe, Yusuke, Misawa, Naoko, Nakaoka, Shinji, Koyanagi, Yoshio, Perelson, Alan S, Schoggins, John W, Iwami, Shingo, Sato, Kei
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 4
container_start_page
container_title PLoS computational biology
container_volume 18
creator Kumata, Ryuichi
Iwanami, Shoya
Mar, Katrina B
Kakizoe, Yusuke
Misawa, Naoko
Nakaoka, Shinji
Koyanagi, Yoshio
Perelson, Alan S
Schoggins, John W
Iwami, Shingo
Sato, Kei
description In HIV-1-infected individuals, transmitted/founder (TF) virus contributes to establish new infection and expands during the acute phase of infection, while chronic control (CC) virus emerges during the chronic phase of infection. TF viruses are more resistant to interferon-alpha (IFN-[alpha])-mediated antiviral effects than CC virus, however, its virological relevance in infected individuals remains unclear. Here we perform an experimental-mathematical investigation and reveal that IFN-[alpha] strongly inhibits cell-to-cell infection by CC virus but only weakly affects that by TF virus. Surprisingly, IFN-[alpha] enhances cell-free infection of HIV-1, particularly that of CC virus, in a virus-cell density-dependent manner. We further demonstrate that LY6E, an IFN-stimulated gene, can contribute to the density-dependent enhancement of cell-free HIV-1 infection. Altogether, our findings suggest that the major difference between TF and CC viruses can be explained by their resistance to IFN-[alpha]-mediated inhibition of cell-to-cell infection and their sensitivity to IFN-[alpha]-mediated enhancement of cell-free infection.
doi_str_mv 10.1371/journal.pcbi.1010053
format Article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A702007975</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A702007975</galeid><sourcerecordid>A702007975</sourcerecordid><originalsourceid>FETCH-LOGICAL-g1355-e8987733256c305eb24fb43cab023b4694eb0aed66d083ec29c571cd123270b03</originalsourceid><addsrcrecordid>eNqVjVFLwzAUhYMoOKf_wIeCTz6k3jRN0z6WoW4wFNSJIDLS9GbL6JLRZuDPt2MiDnyR-3DuPXznXEIuGcSMS3az8tvWqSbe6MrGDBiA4EdkwITgVHKRH__s6dspOeu6FUBvF9mAzEoXbFhisDpCY1CHyJvIuoCtwdY7-q6azVJ9RN5FGpuGmhYxUq7eX8HTnUbjyStlfWxXYL07JydGNR1efOuQzO5uX0ZjOn28n4zKKV0wLgTFvMil5DwRmeYgsEpSU6VcqwoSXqVZkWIFCussqyHnqJNCC8l0zRKeSKiAD8nVvnehGpz3731olV7bTs9LCQmALKToqfgPqp8a11Z7h8b2_kHg-iDQMwE_w0Jtu24-eX76B_vwm_0Cza5_NA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Antithetic effect of interferon-[alpha] on cell-free and cell-to-cell HIV-1 infection</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Public Library of Science (PLoS)</source><source>PubMed Central</source><creator>Kumata, Ryuichi ; Iwanami, Shoya ; Mar, Katrina B ; Kakizoe, Yusuke ; Misawa, Naoko ; Nakaoka, Shinji ; Koyanagi, Yoshio ; Perelson, Alan S ; Schoggins, John W ; Iwami, Shingo ; Sato, Kei</creator><creatorcontrib>Kumata, Ryuichi ; Iwanami, Shoya ; Mar, Katrina B ; Kakizoe, Yusuke ; Misawa, Naoko ; Nakaoka, Shinji ; Koyanagi, Yoshio ; Perelson, Alan S ; Schoggins, John W ; Iwami, Shingo ; Sato, Kei</creatorcontrib><description>In HIV-1-infected individuals, transmitted/founder (TF) virus contributes to establish new infection and expands during the acute phase of infection, while chronic control (CC) virus emerges during the chronic phase of infection. TF viruses are more resistant to interferon-alpha (IFN-[alpha])-mediated antiviral effects than CC virus, however, its virological relevance in infected individuals remains unclear. Here we perform an experimental-mathematical investigation and reveal that IFN-[alpha] strongly inhibits cell-to-cell infection by CC virus but only weakly affects that by TF virus. Surprisingly, IFN-[alpha] enhances cell-free infection of HIV-1, particularly that of CC virus, in a virus-cell density-dependent manner. We further demonstrate that LY6E, an IFN-stimulated gene, can contribute to the density-dependent enhancement of cell-free HIV-1 infection. Altogether, our findings suggest that the major difference between TF and CC viruses can be explained by their resistance to IFN-[alpha]-mediated inhibition of cell-to-cell infection and their sensitivity to IFN-[alpha]-mediated enhancement of cell-free infection.</description><identifier>ISSN: 1553-734X</identifier><identifier>EISSN: 1553-7358</identifier><identifier>DOI: 10.1371/journal.pcbi.1010053</identifier><language>eng</language><publisher>Public Library of Science</publisher><subject>Care and treatment ; Health aspects ; HIV infection ; Interferon alpha</subject><ispartof>PLoS computational biology, 2022-04, Vol.18 (4)</ispartof><rights>COPYRIGHT 2022 Public Library of Science</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,27903,27904</link.rule.ids></links><search><creatorcontrib>Kumata, Ryuichi</creatorcontrib><creatorcontrib>Iwanami, Shoya</creatorcontrib><creatorcontrib>Mar, Katrina B</creatorcontrib><creatorcontrib>Kakizoe, Yusuke</creatorcontrib><creatorcontrib>Misawa, Naoko</creatorcontrib><creatorcontrib>Nakaoka, Shinji</creatorcontrib><creatorcontrib>Koyanagi, Yoshio</creatorcontrib><creatorcontrib>Perelson, Alan S</creatorcontrib><creatorcontrib>Schoggins, John W</creatorcontrib><creatorcontrib>Iwami, Shingo</creatorcontrib><creatorcontrib>Sato, Kei</creatorcontrib><title>Antithetic effect of interferon-[alpha] on cell-free and cell-to-cell HIV-1 infection</title><title>PLoS computational biology</title><description>In HIV-1-infected individuals, transmitted/founder (TF) virus contributes to establish new infection and expands during the acute phase of infection, while chronic control (CC) virus emerges during the chronic phase of infection. TF viruses are more resistant to interferon-alpha (IFN-[alpha])-mediated antiviral effects than CC virus, however, its virological relevance in infected individuals remains unclear. Here we perform an experimental-mathematical investigation and reveal that IFN-[alpha] strongly inhibits cell-to-cell infection by CC virus but only weakly affects that by TF virus. Surprisingly, IFN-[alpha] enhances cell-free infection of HIV-1, particularly that of CC virus, in a virus-cell density-dependent manner. We further demonstrate that LY6E, an IFN-stimulated gene, can contribute to the density-dependent enhancement of cell-free HIV-1 infection. Altogether, our findings suggest that the major difference between TF and CC viruses can be explained by their resistance to IFN-[alpha]-mediated inhibition of cell-to-cell infection and their sensitivity to IFN-[alpha]-mediated enhancement of cell-free infection.</description><subject>Care and treatment</subject><subject>Health aspects</subject><subject>HIV infection</subject><subject>Interferon alpha</subject><issn>1553-734X</issn><issn>1553-7358</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqVjVFLwzAUhYMoOKf_wIeCTz6k3jRN0z6WoW4wFNSJIDLS9GbL6JLRZuDPt2MiDnyR-3DuPXznXEIuGcSMS3az8tvWqSbe6MrGDBiA4EdkwITgVHKRH__s6dspOeu6FUBvF9mAzEoXbFhisDpCY1CHyJvIuoCtwdY7-q6azVJ9RN5FGpuGmhYxUq7eX8HTnUbjyStlfWxXYL07JydGNR1efOuQzO5uX0ZjOn28n4zKKV0wLgTFvMil5DwRmeYgsEpSU6VcqwoSXqVZkWIFCussqyHnqJNCC8l0zRKeSKiAD8nVvnehGpz3731olV7bTs9LCQmALKToqfgPqp8a11Z7h8b2_kHg-iDQMwE_w0Jtu24-eX76B_vwm_0Cza5_NA</recordid><startdate>20220425</startdate><enddate>20220425</enddate><creator>Kumata, Ryuichi</creator><creator>Iwanami, Shoya</creator><creator>Mar, Katrina B</creator><creator>Kakizoe, Yusuke</creator><creator>Misawa, Naoko</creator><creator>Nakaoka, Shinji</creator><creator>Koyanagi, Yoshio</creator><creator>Perelson, Alan S</creator><creator>Schoggins, John W</creator><creator>Iwami, Shingo</creator><creator>Sato, Kei</creator><general>Public Library of Science</general><scope>ISN</scope><scope>ISR</scope></search><sort><creationdate>20220425</creationdate><title>Antithetic effect of interferon-[alpha] on cell-free and cell-to-cell HIV-1 infection</title><author>Kumata, Ryuichi ; Iwanami, Shoya ; Mar, Katrina B ; Kakizoe, Yusuke ; Misawa, Naoko ; Nakaoka, Shinji ; Koyanagi, Yoshio ; Perelson, Alan S ; Schoggins, John W ; Iwami, Shingo ; Sato, Kei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g1355-e8987733256c305eb24fb43cab023b4694eb0aed66d083ec29c571cd123270b03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Care and treatment</topic><topic>Health aspects</topic><topic>HIV infection</topic><topic>Interferon alpha</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kumata, Ryuichi</creatorcontrib><creatorcontrib>Iwanami, Shoya</creatorcontrib><creatorcontrib>Mar, Katrina B</creatorcontrib><creatorcontrib>Kakizoe, Yusuke</creatorcontrib><creatorcontrib>Misawa, Naoko</creatorcontrib><creatorcontrib>Nakaoka, Shinji</creatorcontrib><creatorcontrib>Koyanagi, Yoshio</creatorcontrib><creatorcontrib>Perelson, Alan S</creatorcontrib><creatorcontrib>Schoggins, John W</creatorcontrib><creatorcontrib>Iwami, Shingo</creatorcontrib><creatorcontrib>Sato, Kei</creatorcontrib><collection>Gale In Context: Canada</collection><collection>Gale In Context: Science</collection><jtitle>PLoS computational biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kumata, Ryuichi</au><au>Iwanami, Shoya</au><au>Mar, Katrina B</au><au>Kakizoe, Yusuke</au><au>Misawa, Naoko</au><au>Nakaoka, Shinji</au><au>Koyanagi, Yoshio</au><au>Perelson, Alan S</au><au>Schoggins, John W</au><au>Iwami, Shingo</au><au>Sato, Kei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antithetic effect of interferon-[alpha] on cell-free and cell-to-cell HIV-1 infection</atitle><jtitle>PLoS computational biology</jtitle><date>2022-04-25</date><risdate>2022</risdate><volume>18</volume><issue>4</issue><issn>1553-734X</issn><eissn>1553-7358</eissn><abstract>In HIV-1-infected individuals, transmitted/founder (TF) virus contributes to establish new infection and expands during the acute phase of infection, while chronic control (CC) virus emerges during the chronic phase of infection. TF viruses are more resistant to interferon-alpha (IFN-[alpha])-mediated antiviral effects than CC virus, however, its virological relevance in infected individuals remains unclear. Here we perform an experimental-mathematical investigation and reveal that IFN-[alpha] strongly inhibits cell-to-cell infection by CC virus but only weakly affects that by TF virus. Surprisingly, IFN-[alpha] enhances cell-free infection of HIV-1, particularly that of CC virus, in a virus-cell density-dependent manner. We further demonstrate that LY6E, an IFN-stimulated gene, can contribute to the density-dependent enhancement of cell-free HIV-1 infection. Altogether, our findings suggest that the major difference between TF and CC viruses can be explained by their resistance to IFN-[alpha]-mediated inhibition of cell-to-cell infection and their sensitivity to IFN-[alpha]-mediated enhancement of cell-free infection.</abstract><pub>Public Library of Science</pub><doi>10.1371/journal.pcbi.1010053</doi></addata></record>
fulltext fulltext
identifier ISSN: 1553-734X
ispartof PLoS computational biology, 2022-04, Vol.18 (4)
issn 1553-734X
1553-7358
language eng
recordid cdi_gale_infotracmisc_A702007975
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Public Library of Science (PLoS); PubMed Central
subjects Care and treatment
Health aspects
HIV infection
Interferon alpha
title Antithetic effect of interferon-[alpha] on cell-free and cell-to-cell HIV-1 infection
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T22%3A28%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antithetic%20effect%20of%20interferon-%5Balpha%5D%20on%20cell-free%20and%20cell-to-cell%20HIV-1%20infection&rft.jtitle=PLoS%20computational%20biology&rft.au=Kumata,%20Ryuichi&rft.date=2022-04-25&rft.volume=18&rft.issue=4&rft.issn=1553-734X&rft.eissn=1553-7358&rft_id=info:doi/10.1371/journal.pcbi.1010053&rft_dat=%3Cgale%3EA702007975%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A702007975&rfr_iscdi=true